Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines

Protein Engineering, Design and Selection

Volumn 27, Issue 7, 2014, Pages 235-243

  Bedi, Deepa ^a,b   Gillespie, James W ^a   Petrenko, Valery A ^a  

^a AUBURN UNIVERSITY   (United States)

^b TUSKEGEE UNIVERSITY   (United States)

Author keywords

drug delivery; landscape phage; liposome major coat protein pVIII; pancreatic cancer phage display

Indexed keywords

CELLS; CHEMOTHERAPY; DRUG DELIVERY; LIPOSOMES; TUMORS;

COAT PROTEINS; HIGH-THROUGHPUT APPROACHES; LANDSCAPE PHAGES; PANCREATIC CANCERS; STRAIGHT-FORWARD METHOD; TARGETED DRUG DELIVERY SYSTEMS; TARGETING LIGANDS; THERAPEUTIC INDEX;

PROTEINS;

DOXORUBICIN; HYBRID PROTEIN; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; PEPTIDE LIBRARY;

ARTICLE; BILAYER MEMBRANE; BREAST EPITHELIUM; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOMEDICINE; PANCREAS CANCER; PRIORITY JOURNAL; TARGET CELL; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RESISTANCE; ENZYME SPECIFICITY; METABOLISM; MOLECULAR GENETICS; PANCREAS TUMOR; PATHOLOGY; PEPTIDE LIBRARY; PROCEDURES; PROTEIN TRANSPORT; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; NANOMEDICINE; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; PEPTIDE LIBRARY; POLYETHYLENE GLYCOLS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84903711079     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzu020     Document Type: Article

References (44)

1. Aida, Y. and Pabst, M.J. (1990) J. Immunol. Methods, 132, 191-195.
2. Aina, O.H., Liu, R., Sutcliffe, J.L., Marik, J., Pan, C.X. and Lam, K.S. (2007) Mol. Pharm., 4, 631-651.
3. Alexis, F., Rhee, J.W., Richie, J.P., Radovic-Moreno, A.F., Langer, R. and Farokhzad, O.C. (2008) Urol. Uncol., 26, 74-85.
4. Brigati, J.R., Samoylova, T.I., Jayanna, P.K. and Petrenko, V.A. (2008) Curr. Protoc. Protein Sci., Chapter 18, Unit 18-9, 3 (Suppl 51), 1-27.
5. Broome-Smith, J.K., Gnaneshan, S., Hunt, L.A., Mehraein-Ghomi, F., Hashemzadeh-Bonehi, L., Tadayyon, M. and Hennessey, E.S. (1994) Mol. Membr. Biol., 11, 3-8.
6. Cleary, S.P., Gryfe, R., Guindi, M., et al. (2004) J. Am. Coll. Surg., 198, 722-731.
7. El Kamar, F.G., Grossbard, M.L. and Kozuch, P.S. (2003) Oncologist, 8, 18-34.
8. Fagbohun, O.A., Bedi, D., Grabchenko, N.I., Deinnocentes, P.A., Bird, R.C. and Petrenko, V.A. (2012) Protein Eng. Des. Sel., 25, 271-283.
9. Goren, D., Horowitz, A.T., Tzemach, D., Tarshish, M., Zalipsky, S. and Gabizon, A. (2000) Clin. Cancer Res., 6, 1949-1957.
10. Gottesman, M.M., Pastan, I. and Ambudkar, S.V. (1996) Curr. Opin. Genet. Dev., 6, 610-617.
11. Gray, B.P. and Brown, K.C. (2014) Chem. Rev., 114, 1020-1081.
12. Houbiers, M.C., Spruijt, R.B., Demel, R.A., Hemminga, M.A. and Wolfs, C.J.A.M. (2001) Biochim. Biophys. Acta, 1511, 309-316.
13. Jayanna, P.K., Torchilin, V.P. and Petrenko, V.A. (2009) Nanomedicine, 5, 83-89.
14. Jayanna, P.K., Bedi, D., Gillespie, J.W., DeInnocentes, P., Wang, T., Torchilin, V.P., Bird, R.C. and Petrenko, V.A. (2010) Nanomedicine, 6, 538-546.
15. Jemal, A., Thomas, A., Murray, T. and Thun, M. (2002) CA Cancer J. Clin., 52, 23-47.
16. Koivunen, E., Arap, W., Valtanen, H., et al. (1999) Nat. Biotechnol., 17, 768-774.
17. Krumpe, L.R. and Mori, T. (2006) Int. J. Pept. Res. Ther., 12, 79-91.
18. Kuhn, A. (1995) FEMS Microbiol. Rev., 17, 185-190.
19. Lamy, T., Drenou, B., Grulois, I., et al. (1995) Leukemia, 9, 1549-1555.
20. Lee, S., Meslsh, M.F. and Opella, S.J. (2003) J. Biomol. NMR, 26, 327-334.
21. Lee, T.Y., Wu, H.C., Tseng, Y.L. and Lin, C.T. (2004) Cancer Res., 64, 8002-8008.
22. Maeda, H. (2001) Adv. Enzyme Regul., 41, 189-207.
23. Medina, O.P., Soderlund, T., Laakkonen, L.J., Tuominen, E.K., Koivunen, E. and Kinnunen, P.K. (2001) Cancer Res., 61, 3978-3985.
24. Molinari, M., Helton, W.S. and Espat, N.J. (2001) Surg. Clin. North Am., 81, 651-666.
25. Moore, M.J., Goldstein, D., Hamm, J., et al. (2007) J. Clin. Oncol., 25, 1960-1966.
26. Mori, T. (2004) Curr. Pharm. Des., 10, 2335-2343.
27. Noble, C.O., Kirpotin, D.B., Hayes, M.E., Mamot, C., Hong, K., Park, J.W., Benz, C.C., Marks, J.D. and Drummond, D.C. (2004) Expert Opin. Ther. Targets, 8, 335-353.
28. O'Driscoll, L., Walsh, N., Larkin, A., et al. (2007) Anticancer Res., 27, 2115-2120.
29. Oettle, H. and Neuhaus, P. (2007) Drugs, 67, 2293-2310.
30. Oyama, T., Sykes, K.F., Samli, K.N., Minna, J.D., Johnston, S.A. and Brown, K.C. (2003) Cancer Lett., 2, 219-230.
31. Pastorino, F., Brignole, C., DiPaolo, D., et al. (2006) Cancer Res., 66, 10073-10082.
32. Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R. and Langer, R. (2007) Nat. Nanotechnol., 2, 751-760.
33. Petrenko, V.A. (2008) Expert Opin. Drug Deliv., 5, 825-836.
34. Petrenko, V.A. and Jayanna, P.K. (2014) FEBS Lett., 2, 341-349.
35. Petrenko, V.A. and Smith, G.P. (2000) Protein Eng., 13, 589-592.
36. Petrenko, V.A., Smith, G.P., Gong, X. and Quinn, T. (1996) Protein Eng., 9, 797-801.
37. Sergeeva, A., Kolonin, M.G., Molldrem, J.J., Pasqualini, R. and Arap, W. (2006) Adv. Drug Deliv. Rev., 58, 1622-1654.
38. Smith, G.P., Petrenko, V.A. and Matthews, L.J. (1998) J. Immunol. Methods, 215, 151-161.
39. Soekarjo, M., Eisenhawer, M., Kuhn, A. and Vogel, H. (1996) Biochemistry, 35, 1232-1241.
40. Sofou, S. (2007) Nanomedicine, 2, 711-724.
41. Tsai, C.S., Park, J.W. and Chen, L.T. (2011) J. Gastrointest. Oncol., 2, 185-194.
42. Vlerken, V.I.E., Vyas, T.K. and Amiji, M.M. (2007) Pharm. Res., 24, 1405-1414.
43. Wang, T., D'Souza, G.G., Bedi, D., Fagbohun, O.A., Potturi, L.P., Papahadjopoulos-Sternberg, B., Petrenko, V.A. and Torchilin, V.P. (2010) Nanomedicine, 5, 563-574.
44. Wang, T., Hartner, W.C., Gillespie, J.W., Praveen, K.P., Yang, S., Mei, L.A., Petrenko, V.A. and Torchilin, V.P. (2014) Nanomedicine, 10, 421-430.